 | Up a level |
2017
Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., Jenkin, G., Jensen, W., Kim, Y. -S., Yoshida, J., Gabryelski, L., Pedley, A., Eves, K., Tipping, R., Guris, D., Kartsonis, N. and Dorr, M. -B. (2017). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N. Engl. J. Med., 376 (4). S. 305 - 318. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
2016
Gerding, D. N., Hecht, D. W., Louie, T., Nord, C. E., Talbot, G. H., Cornely, O. A., Buitrago, M., Best, E., Sambol, S., Osmolski, J. R., Kracker, H., Locher, H. H., Charef, P. and Wilcox, M. (2016). Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection. J. Antimicrob. Chemother., 71 (1). S. 213 - 220. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091